Clinical Trial

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Trial Details
NCT Number NCT07179055
Lead Sponsor Vanda Pharmaceuticals
Conditions Dry Eye
Enrollment 160 participants
Start Date 2025-10
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-17